JEGHAM SAMIR,BOURRIE BERNARD,CASELLAS PIERRE,COSNIER-PUCHEU SYLVIE,PERREAUT PIERRE
申请号：
TN2014000382
公开号：
TN2014000382A1
申请日:
2014.09.10
申请国别(地区):
TN
年份:
2015
代理人:
摘要：
The present invention relates to combinations of N-[2-(2,1,3-benzothiadiazol-5- ylamino)-6-(2,6-dichlorophenyl) pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)-urea and cytarabine and their use for treating AML or CML.
